DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Khan O, Rieckmann P, Boyko A. , et al.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Mult Scler 2017;
23 (06) 818-829
We do not assume any responsibility for the contents of the web pages of other providers.